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O lmsted syndrome (OS) (OMIM 14594) is a rare geno-dermatosis characterized by extensive palmoplantarkeratoderma(PPK)andperiorificial keratoticplaques.1
Initially, these 2 features were considered diagnostic hall-
marks of this syndrome. However, review of the literature
reveals thatOS encompasses awide range of clinicalmanifes-
tations, includingvariable features suchas alopecia, constrict-
ingdigital bands,or spontaneousdigit amputation.2,3This con-
dition is therefore sometimes difficult to diagnose because of
clinical overlap with other palmoplantar keratodermas. The
total number of reported cases is approximately 50, of which
12 cases are familial, with differentmodes of inheritance. Re-
cently,exomesequencing identifieddenovoheterozygousmis-
sensemutations inTRPV3 (transient receptor potential vanil-
loid 3), encoding a cation channel, in autosomal-dominant
OS.4-6Threedominantgain-of-functionmutations,p.Gly573Ser
(4 patients), p.Gly573Cys (1 patient), and p.Trp692Gly (1 pa-
tient),were first described in 5 sporadic and 1 familialOS cases
inChinesepatients.5 Subsequently, other exomestudies iden-
tified the heterozygous p.Gly573Ser and p.Gly573Ala muta-
tions inan Indianpatient andawhitepatientwith sporadicOS,
respectively.4,6 Recently, a heterozygous missense mutation
(p.Phe464Ser) in MBTPS2 (membrane-bound transcription
factor protease, site 2), encoding a zinc metalloprotease, was
detected in 2 related patients with X-linked recessive OS by
means of exome sequencing, providing evidence for clinical
and genetic heterogeneity in OS.7
Report of a Case
We studied a young girl, born at term after a normal preg-
nancy and delivery to healthy and nonconsanguineous par-
ents. Her clinical symptoms started at birth with superficial
peeling of the toeswithout hyperkeratosis or blistering. Plan-
tar keratoderma developed after she startedwalking at 1 year
of age, initially distributed in islands on the pressure points
and gradually extending to most of the plantar surface, with
no transgrediens extensionbutdramatic thickeningover time
(Figure 1A and B). There was neither periorificial hyperkera-
tosis nor constriction or mutilation of the digits. A remark-
able feature was that plantar keratoderma was associated at
least since 3 years of age (age at diagnosis) with intense acute
flares of severe itching, burning pain, erythema, andwarmth
in the extremities (hands, feet, and ears) and venous dilata-
tion, consistent with erythromelalgia, triggered by heat
IMPORTANCE Olmsted syndrome (OS) is a rare keratinizing disorder characterized by
excessive epidermal thickening of the palms and soles, with clinical and genetic
heterogeneity. Approximately 50 cases have been reported, with themolecular basis
described in only 9. Recently, TRPV3 (transient receptor potential vanilloid 3) mutations were
identified in autosomal-dominant OS in 7 sporadic cases and 1 familial case, whereas an
MBTPS2 (membrane-bound transcription factor protease, site 2) mutation was reported in
X-linked recessive OS. We report a new sporadic case of severe, atypical OS and its underlying
genetic basis.
OBSERVATIONS Our patient is a young girl with severe nonmutilating (palmo)plantar
keratoderma without periorificial keratotic plaques associated with intense acute flares of
inflammation, itching, burning pain, vasodilatation, and redness of the extremities consistent
with erythromelalgia. Whole exome sequencing of patient DNA identified a novel de novo
heterozygous missensemutation within TRPV3, p.Leu673Phe, predicted to be damaging.
CONCLUSIONS AND RELEVANCE This case study further implicates TRPV3 in OS pathogenesis.
In addition, previous reports of OS have not described erythromelalgia as a clinical feature. Its
occurrence in our patient could be a chance event, but, if associated with OS, the features of
erythromelalgia may expand the phenotypic spectrum of this rare syndrome.
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(Figure 1C and D). Because of extreme foot pain, she walked
on knees and hands, which resulted in mild palmar kerato-
derma,andhasbeenusingawheelchair since theageof3years.
Immersion in coldwater, use of a fan, and treatmentwith sys-
temic and topical steroids reduced pain. Her fingernails and
toenailswere thin andbrittle.Herhairwas fine, dry, curly, and
unmanageable (Figure1D).Microscopicexaminationof thehair
showed superficial irregularities without specific abnormali-
ties under polarizing microscopy. Sweating was enhanced. A
skin biopsy sample stained with hematoxylin-eosin showed
hyperplastic epidermiswithhyperkeratosis, parakeratosis, hy-
pergranulosis, and papillomatosis (Figure 1E).
Differential diagnoses included erythromelalgia; pachyo-
nychia congenita (OMIM 167200 and OMIM 167210), in which
nails can in rare cases show no thickening; and OS. However,
no mutation in SCN9A, encoding the voltage-gated sodium
channel α subunitNav1.7,which is defective inprimary eryth-
romelalgia (OMIM 133020), or in KRT6A, KRT6B, KRT16, and
KRT17, which are mutated in pachyonychia congenita, was
identified in the patient by sequencing.8,9 Although our pa-
tient showed no periorificial hyperkeratosis, which was ini-
tiallyconsideredamajorOSdiagnostic featurebuthasalsobeen
reported to be absent in rare OS cases, the severity of plantar
keratoderma seen in our patient, the cutaneous features, and
the clinical course of the disease were highly suggestive of
OS.3,4Whenwe initiated this study, thegenetic basis ofOSwas
unknown, and mutations in TRPV3 and MBTPS2 were re-
ported during our analysis.
To identify the genetic cause underlying this disease, we
performed whole-exome sequencing in this patient (see
eMethods in Supplement). Analysis of exomedata focusedon
candidate genes, ie, keratin genes and other genes involved
inPPKs.We identifiednocausativemutationexcept inTRPV3,
which carried 1 heterozygous c.2017C>T substitution
(NM_001258205.1) in exon 15 leading to p.Leu673Phe.We first
confirmed the occurrence of this genetic variant in the pa-
tientbymeansofSanger sequencingofgenomicDNAandmes-
senger RNA (see eMethods in Supplement). Sequencing
showed that the c.2017C>T variation was absent in both par-
ents, indicating that itwas a denovomissensemutation. This
variant was not found in 6503 individuals from the National
Heart, Lung, and Blood Institute Exome Sequencing Project,
in 100 normal controls, or in 253 in-house exomes.
TRPV3 is a thermosensitive cation nonselective channel,
predominantlyexpressed inkeratinocytes and in sensoryneu-
rons. This polymodal channel assembles as tetramers and is
activated by temperature (31°C-39°C) and several chemical
ligands.10 Remarkably, the 3 dominant missense gain-of-
function TRPV3 mutations (p.Gly573Cys, p.Gly573Ser, and
p.Trp692Gly) recently identified inpatientswithOS leadtocon-
stitutiveactivity inmutant channels, resulting inenhancedke-
ratinocyte apoptosis and hyperkeratosis.4,5
Thep.Leu673Phevariant identified inourpatientwaspre-
dicted to bedamaging by in silico prediction tools (SIFT, Poly-
phen2,PANTHER,LRT,andMutationTaster). Inaddition,align-
ment of TRPV3 orthologues showed that Leu673 is highly
conserved among species, suggesting functional importance
(Figure 2A). The p.Leu673Phe and the p.Trp692Gly muta-
tions are located in the cytoplasmic C-terminal of the mol-
ecule. However, in contrast to the p.Trp692Gly mutation,
p.Leu673Phe is not located in the transient receptor potential
(TRP) box of the TRP domain. The TRP domain, a conserved
Figure 1. Clinical Features
A B C
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A, Plantar keratoderma initially
developed in islands on pressure
points of the soles and first toes, with
localized redness and peeling of the
skin (2 years). B, The lesions rapidly
extended to the bases of all toes,
to heels, and to forefeet, associated
with peripheral skin inflammation
(5 years). Hyperkeratosis became
massive and dramatic on the right
sole, with intense itching and pain
causingmajor disability. C and D,
Ears, toes, and feet became red,
swollen, and extremely painful during
flares of erythromelalgia. D, Hair was
thin, curly, and unmanageable.
E, Skin biopsy showing hyperplastic
epidermis with hyperkeratosis,
parakeratosis, hypergranulosis, and
papillomatosis. Capillaries are dilated
in the upper dermis
(hematoxylin-eosin, original
magnification, ×100).
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cytoplasmic region of all TRP channel families, has been pro-
posed tohave a role in subunitmultimerization, channel con-
formation and gating, functional coupling of stimulus sens-
ing, and pore opening.11,12 The p.Leu673Phe nonconservative
missensemutationpredominantlychanges thesize rather than
thechemistryof residue673 (thePhesidechain is 22.7Å2 larger
in surface area than Leu). A TRPV3homologymodelwas gen-
eratedto locate themutatedresiduewithinanassembledchan-
nel complex (Figure 2B) (see eFigure andeMethods in Supple-
ment).Theenergy-minimizedmodel revealed thatLeu673was
situated immediately above thepredicted activationgate resi-
due (Met677)ontheprecedinghelical turn (Figure2C).Whereas
a direct effect on channel gating is conceivable, several seg-
ments capable of influencing channel activity intersect at this
position (theS4-5 linker, S6 transmembranehelix, and theTRP
domain). The mechanism by which the p.Leu673Phe muta-
tion alters TRPV3 function must await future studies. Thus,
all these results suggested that this variant is likely to be the
mutation responsible for PPK in our patient.
Discussion
Because of the limited number of OS cases with known ge-
netic basis, genotype-phenotype correlations remain elusive.
However, noticeabledifferences areobservedevenamongpa-
tientswithOSwithTRPV3mutations. These discrepancies in-
clude the severity of symptoms and the presence or absence
of constrictingdigit bands, spontaneousdigit amputation,hair
anomalies,naildefects, and/orperiorificial keratosis.2-6Hair in-
volvement varies, ranging from alopecia to thinning, coarse,
dry, and curly hair.2,3 In contrast to our patient, previously re-
ported patients with OS had normal, absent, or more com-
monlydystrophicnails.2,3 Therefore, phenotypic variability in
OS can result from allelic or nonallelic genetic heterogeneity,
modifier genes, and/or environmental factors.
None of the previously reported OS cases had features
suggestive of erythromelalgia. Most cases of erythromelalgia
are idiopathic (primary erythromelalgia); others occur sec-
ondary to medical conditions.13 Primary erythromelalgia is
an inherited condition with autosomal-dominant inheritance
and is mostly caused by mutation in SCN9A, but other genes
remain to be identified.8 Reported secondary causes of eryth-
romelalgia include disorders such as neurological, autoim-
mune, or hematological diseases for which we have no evi-
dence in our patient.13 Because we report a sporadic case, we
could not explore cosegregation of erythromelalgia with OS
in this family. Thus, we cannot establish whether cooccur-
rence of erythromelalgia and OS in our patient is coincidental
or is part of the phenotypic spectrum of OS. Although no
mutation in SCN9A was identified, we could not formally
exclude the occurrence of an additional de novo mutation in
a second gene in our patient with no familial history of eryth-
romelalgia. Conversely, TRPV3 is implicated in skin inflam-
mation and nociceptive signaling, suggesting that symptoms
of erythromelalgia could also result from the consequences
of the TRPV3 mutation identified in our patient.14 Atypical
cases lacking classical OS clinical features and presenting
with additional unusual manifestations, such as corneal dys-
plasia, hearing loss, or squamous cell carcinoma, have been
previously reported, supporting clinical heterogeneity in
OS.2,3,15 The identification of similar cases with OS associated
Figure 2. Localization andModeling of the TRPV3Mutation
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A, Alignment of TRPV3 orthologues
showing part of the C-terminal
domain. Transmembrane domain S6
and the TRP domain and box are
indicated. Leu673 (indicated in blue)
is a highly conserved residue. The
mutated residue (Trp692Gly)
previously identified in Olmsted
syndrome is indicated in green.
B, Overview of a homotetrameric
TRPV3 channel (each color
represents a different TRPV3
molecule). Non-S6 segments are
transparent to highlight S6 helices.
Leu673 is located at the S6 base
(dashed black rectangle). C, Enlarged
representation of the TRPV3
activation gate sealed byMet677,
which is directly below Leu673.
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with erythromelalgia will be necessary to link erythromelal-
gia to OS and TRPV3mutation.
Conclusions
In summary, our findings identify a novelmissensemutation
in TRPV3 and corroborate that TRPV3 mutations are recur-
rent in autosomal-dominantOS. Our findings further support
the notion that TRPV3 is a major gene in OS physiopathogen-
esis. We report for the first time, to our knowledge, the asso-
ciation of OS with severe erythromelalgia in 1 sporadic case,
which could be incidental or expands the spectrum of atypi-
calmanifestations associatedwithOS. Themolecularmecha-
nisms throughwhich thisTRPV3mutationalters channel func-
tion and leads to OS are yet to be determined.
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